Invention Grant
- Patent Title: Stable aqueous anti-vascular endothelial growth factor (VEGF) antibody formulation
-
Application No.: US15546370Application Date: 2016-01-20
-
Publication No.: US10894083B2Publication Date: 2021-01-19
- Inventor: Rebecca Lee Ingram , Sarah Elizabeth Weiser
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Stephen E. Moyer
- International Application: PCT/IB2016/050273 WO 20160120
- International Announcement: WO2016/120753 WO 20160804
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/22
Abstract:
The present invention relates to the field of pharmaceutical formulations of antibodies. Specifically, the present invention relates to a stable liquid antibody formulation and its pharmaceutical preparation and use. This invention is exemplified by an aqueous formulation of an anti-vascular endothelial growth factor (VEGF) antibody.
Public/Granted literature
- US20180000933A1 STABLE AQUEOUS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) ANTIBODY FORMULATION Public/Granted day:2018-01-04
Information query
